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Dissertation Abstract  
Antibiotic resistance (ABR), alternately referred to as antimicrobial resistance, has 
been labelled as the next big global health crisis. If current levels of ABR continue along the 
same trajectories, by 2050 ABR will cost the lives of 10 million people a year, ABR cannot be 
stopped but it can be slowed down. ABR occurs because the bacteria evolve to protect 
themselves from antibiotics. One of the main causes of ABR is the misuse and over 
prescription of antibiotics. The primary objective of the study is to ascertain the level of 
knowledge, attitudes and perceptions of appropriate antibiotic use and ABR, among 
prescribers and patients in private health care in South Africa. The secondary objective of 
the study is to explore associations between knowledge, attitudes and perceptions of 
prescribers and patients regarding antibiotic use and resistance.  
This project consists of three main sections, a proposal, literature review and a 
journal ready article. All sections focus on ABR. The proposal lays a foundation for the need 
for the research, and explains how the research will be conducted. The literature review 
explores the existing evidence on the topic, and the final section is a secondary analysis of 
cross sectional study data, in which private practice patients and prescribers in South Africa 
completed a once-off anonymous survey. Data was analysed using Stata, T-tests, chi-
squared tests, logistic regression models were used to assess associations between 
knowledge, attitudes and perceptions of both patients and prescribers.   
We found that mean knowledge scores among patients (n=403, mean 9 out of 14, 
standard deviation [SD] 3) and providers (n=175, median 5 maximum 7, IQR 4, 6), were 
suboptimal and that poor knowledge was associated with perceptions and behaviours as 
well as prescribing practices that could lead to ABR. Associations between knowledge, 
attitudes and perceptions of patients and prescribers were explored in multivariate logistic 
regression models. After adjusting for education and sex, a 1-unit increase in patient 
knowledge score was associated with the belief that antibiotics will work less well in future if 
we over-use them now (aOR 1.3; 95% CI: 1.18, 1.43; pvalue <0.001). Prescribers with 
higher knowledge scores were less likely to report that they prescribe antibiotics when not 
necessary as antibiotics cannot harm the patient (aOR 0.55; 95% CI: 0.33, 0.91; pvalue 
0.02). We also identified a large proportion (58%) of patients who were interested in 
alternatives to antibiotics and a large proportion (91%) of prescribers wanting educational 
material to facilitate conversations about resistance with patients. 
Our study demonstrates gaps in patient and prescriber knowledge that are 
associated with potentially harmful perceptions and destructive behaviours regarding 
antibiotic use. These associations, together with our finding that patients and prescribers 
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would like more education on ABR, suggest that educational tools and patient-provider 
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Part A: Protocol 
 
Title: Knowledge, attitudes and perceptions of antibiotic use and antibiotic resistance 
among private sector patients’ and prescribers’ in South Africa 
 
Purpose of the Study 
The primary objective of the study is to ascertain the level of knowledge, attitudes and 
perceptions of appropriate antibiotic use and antibiotic resistance (ABR), otherwise known 
as antimicrobial resistance, among prescribers and patients in South Africa. The secondary 
objective of the study is to explore associations between knowledge, attitudes and 
perceptions of patients and prescribers regarding antibiotic use and resistance. The 
hypothesis the study is that patients and prescribers have differing levels of knowledge, 
attitudes and perceptions about antibiotic use and resistance and that these factors influence 
decisions made, which ultimately impact upon ABR levels. 
ABR is a global issue but is caused by prescribing and use at a local level, so needs 
to be understood locally. If resistance interventions are going to be successful, an 
understanding of current knowledge, attitudes and perceptions of a broad range of patients 
and prescribers need to be understood in a quantitative manner. These questions have been 
asked in other settings (as explored in the literature review section below), but this project 
will be able to offer answers from South African patients and prescribers. This project will 
yield unique insight into antibiotic prescribing, ideas about ABR, and insights into patients’ 
and prescribers’ understanding of the issue of resistance.  
Background 
The World Health Organisation (WHO) states that “antimicrobial resistance, within a wide 
range of infectious agents, is a growing public health threat of broad concern to countries 
and multiple sectors. … (It is a) problem so serious that it threatens the achievements of 
modern medicine. A post-antibiotic era- in which common infections and minor injuries can 
kill- far from being an apocalyptic fantasy, is instead a very real possibility for the 21st 
century” (WHO 2014). 
The word antibiotic was first used in 1941 by Selman Waksman and shortly after 
came the antibiotic age from 1945 – 1955 (Clardy et al. 2009). Penicillin was among the first 
antibiotic medications proved to effectively treat bacterial infections (Spencer 2003). 
Antibiotics have been used to treat conditions such as Whooping Cough, Streptococcal 
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Throat Infections, Urinary Tract Infections and Tuberculosis (CDC 2016). Antibiotics have 
prevented millions of deaths, and the years of biggest impact of these treatments are seen 
as the ‘golden age’. They are hailed as miracle drugs as they can effectively eliminate the 
bacteria without damaging the surrounding cells (Levy 1998). 
ABR occurs because the bacteria evolve to protect themselves from antibiotics. 
Bacteria vary tremendously in their susceptibility to antibiotics. All bacteria are susceptible to 
sufficiently high doses of antibiotics, but the human body cannot tolerate some of these high 
doses, and this introduces the concept of resistance. ABR is either intrinsic (naturally 
occurring) or acquired (Hawkey 1998). Acquired resistance occurs in a ‘survival of the fittest’ 
effort by the bacteria to evolve to ensure protection against antibiotics. 
ABR was first reported in the 1940’s and transferable resistance was first recognised 
in 1959 (Hawkey 1998). The USA reports that 2 million people become infected with 
resistant bacteria each year, and 23 000 people die as a result of these resistant bacterial 
infections (CDC 2016). Reported cases of ABR include diseases such as Tuberculosis, 
Staphylococcusaureus and Methicillin-Resistant Staphylococcus Aureus (MRSA)  (WHO 
2014). The emergence of the Mobilised Colistin Resistance (MCR) -1 gene which renders 
the last line antibiotic, colistin, futile has been the most recent discovery and has hailed calls 
for a united global approach to resistance (Liu 2015). The WHO (2016) has listed many 
concerns about ABR, these include poor surveillance, under reporting (especially of multi-
drug resistant Tuberculosis), and the massive financial and human resource burden this will 
place on health care systems. A recent modelling review on the impact of ABR showed that 
by 2050, 10 million people will die each year as a direct result of resistance and there will be 
between a 2% to 3.5% loss of Global Gross Domestic Product. It will cost the world up to 
100 trillion United States Dollars (USD) (O’Neill 2016). 
One of the main causes of ABR is the misuse and over prescription of antibiotics. 
Antibiotics have been widely misused by humans which has increased the selection and 
spread of resistant bacteria (WHO 2016). The initially produced antibiotics in the 1940’s and 
50’s are currently largely ineffective due to the evolution of antibiotic resistance (Clardy et al. 
2009). The 1980’s were the last years of development of fully effective antibiotics (WHO 
2014).  
It is essential to preserve the efficacy of existing drugs through measures to minimize 
the development and spread of ABR to them, while efforts to develop new treatment options 
proceed (WHO 2014). Antibiotics should only be prescribed and used when absolutely 
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necessary (Levy 1998).  Additions of antibiotics to animal feed should be minimised, as this 
has an unquantifiable impact on resistance levels (Hawkey 1998). 
“Bacteria clearly have a wondrous array of biochemical and genetic systems for 
ensuring the evolution and dissemination of ABR” (Hawkey 1998). Antibiotics have become 
less effective, and ABR will rapidly outpace available treatment options (WHO 2014), and 
the result is a global health crisis. This study aims to understand the perceptions, attitudes 
and knowledge of patients and prescribers in South Africa about antibiotic use and 
resistance. 
Summary of literature review  
Patients’ and prescribers’ knowledge, attitudes and perceptions around antibiotic use and 
ABR will greatly vary from person to person, place to place, and continent to continent. 
There are however several commonalities, some of which this project may show as 
applicable to the South African context. 
Clinicians’ knowledge, attitudes and perceptions of ABR have been assessed in 
multiple studies. The systematic review (including 57 studies) conducted by McCullough et 
al. (2015) on clinicians’ knowledge and beliefs about antibiotic resistance showed that the 
majority of clinicians had heard of ABR and believed it to be a serious issue. A smaller 
percentage believed it was a problem in their own practice. The majority of clinicians noted 
that ABR was mainly from patient non-adherence and excessive antibiotic use (McCullough, 
Rathbone, et al. 2015). An Australian study showed that there was confusion among 
General Practitioners (GPs) about the causes of resistance (Hardy-Holbrook et al. 2013). In 
another Australian based study, it was found that even if GPs are aware of ABR, they do at 
times feel pressure to prescribe antibiotics in order to pacify patients (Tonkin-Crine et al. 
2011). Up to 40% of GP respondents in admitted to prescribing antibiotics to meet patients 
expectations (Hardy-Holbrook et al. 2013). Over prescription is a major issue, in a study 
conducted in India, over 60% of prescriptions were labelled as incorrect (Hadi et al. 2008). 
This could be a consequence of no standardised treatment protocols, or clinicians not 
keeping up to date on the latest treatment evidence. ABR is not only a concern for medical 
professionals. The economic and social impacts of this crisis will be massive (O’Neill 2014), 
and should be taken into consideration. Many medical professionals believe that the 
secondary impacts of ABR will have the biggest impact on society, but as few studies have 
attempted to narrow down actual estimates, there is limited reliable data on what secondary 
impacts can be expected (O’Neill, 2016). There are already international partnerships, 
particularly between Europe and the USA, working on standardised action to slow down 
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resistance (O’Neill, 2016), but this will need to move beyond these regions and into a global 
setting. 
Studies around patients’ knowledge, attitudes and perceptions have revealed that 
globally, there is a massive knowledge gap in regards to ABR,  including within patient 
populations, and decision making and business circles (O’Neill, 2016). Individuals and 
communities show a great deal of uncertainty about resistance, and many people view it as 
a societal problem which will not affect them personally (Brooks et al. 2008). A systematic 
review (54 studies included) conducted by McCullough et al. (2015) on patients’ beliefs and 
knowledge of ABR showed that the majority of patients believed resistance was a change in 
the human body, which made people themselves resistant. Many patients believed that not 
completing antibiotic courses, and excessive antibiotic use led to resistance and most 
patients believed that action to minimise ABR should be done by physicians (McCullough, 
Parekh, et al. 2015). The public also showed signs of confusion, and the majority of 
responses were not in line with prevailing biomedical research (Hawkings et al. 2007). Self-
medication is also an issue, this occurs when patients receive antibiotics from pharmacists 
without having a prescription (Kotwani et al. 2012).This could be a rectifiable issue which 
could decrease overuse of antibiotics. Many patients state that it is not up to them to 
contribute to the control of resistance, but place that role in the hands of GPs (Brooks et al. 
2008). This could be due to the low proportions of GPs who actually discuss ABR with 
patients (Hardy-Holbrook et al. 2013), or the incorrect reporting of ABR in the media. Many 
patients felt ABR was only a problem due to dirty hospitals, and hospital management was to 
blame. Less than a quarter of respondents stated that they could do anything about 
resistance (Hawkings et al. 2007). 
The WHO has limited information on the extent of ABR in Africa as surveillance is 
only carried out in a handful of countries (WHO 2014). Little is known about patients’ and 
prescribers’ knowledge, attitudes and perceptions in the South African context. If the target 
of slowing down ABR is to become a reality, both patients and prescribers will need to be 
involved in the effort. Some instructions for physicians include not acceding to patients’ 
demands for antibiotics, prescribing narrow targeting antibiotics and isolating hospital 
patients with multi-drug resistant infections. Patients should not demand antibiotics, and 
when they are necessary and prescribed, the full course should be taken (Levy 1998). 







Study design  
This project is a secondary analysis based on an original study titled Knowledge, attitudes 
and perceptions of antibiotic use among patients’ and prescribers’ in Cape Town which 
received approval from the University of Cape Town Human Research Ethics Committee 
(HREC REF: 610/2015). The original study was a cross-sectional survey evaluating 
prescribers’ and patients’ knowledge, attitudes and perceptions of antibiotic use and 
resistance. Data from the original study was not analysed, and so this current study will 
evaluate the data that was gathered during the original study. No new data will be collected.  
Objectives  
The main research question of this study is to assess the level of knowledge, attitudes and 
perceptions of ABR among prescribers and patients in South Africa. 
There are four main objectives of the study.  
1. Assess the knowledge that prescribers, General Practitioner Doctors (GPs) and patients 
have about appropriate antibiotic use and the problem of ABR. 
2. Describe the attitudes of prescribers and patients towards antibiotic use and resistance. 
3. Describe the perceptions of prescribers and patients regarding antibiotic use and 
resistance. 
4. Explore associations between knowledge, attitudes and perceptions of prescribers and 
patients regarding antibiotic use and resistance. 
Characteristics of the study population 
Four hundred and three patients and 183 prescribers participated in the original study. 
Participants were included if they were General Practitioner (GPs) in private practice, as well 
as patients attending these practices. People under the age of 18 and not residing in South 
Africa were excluded.  
Recruitment and enrolment 
The original study employed a convenience and snowball-sampling approach. Patients were 
asked by reception staff at GP practices to complete the questionnaire when they arrived for 
consultations. Questionnaires and links to the website where the questionnaire could be 
completed were circulated to GPs who forwarded it on to their colleagues and it was 
presented at a number of academic meetings. Both patient (Appendix 3) and prescriber 
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(Appendix 4) questionnaires were available in soft and hard copies. There was no 
reimbursement for participation in the project. 
Research Procedures and Data Collection Methods 
Data collection for the original project has already been completed. The consent form and 
questionnaire were provided in the language that the participants were most comfortable 
with. Data was collected using online survey forms in multiple-choice style in SurveyMonkey 
(SurveyMonkey Inc., San Mateo, California, USA). Forms completed in hard copy were 
entered into SurveyMonkey by the research team. Data from the online survey was exported 
to Microsoft Excel format.   
Data Safety and Monitoring 
Extracted data will identify individuals only by code. All reports and publications will refer 
only to anonymous or pooled data. Hard copy forms are stored in a locked cupboard, which 
only the research team has access to. Soft copy data is stored in a password protected file, 
only accessible to the research team.  
Data Analysis 
The analysis will be divided into four main sections, to enable the objectives to be met. The 
first will be to evaluate the knowledge questions, the second the questions about 
perceptions, the third about attitudes and the fourth section will look for associations 
between the three previously mentioned sections. The data will be analysed using Stata 
version 14 (StataCorp LP, College Station, TX, USA). The survey questions had multiple-
choice responses. We will therefore report proportions of respondents in each of the 
following: Age category, Professional Healthcare Group, proportions of correct responses to 
knowledge questions, proportions of participants exhibiting specific attitudes and 
perceptions. 
In order to ascertain the level of knowledge of the respondents, a score will be 
assigned to each participant (out of 7 for prescribers and 14 for patients). Descriptive 
statistics and proportions will be used to show patterns about the attitudes and perceptions 
of respondents. Correct answers in the knowledge sections will be used to assess the 
proportion of knowledge each respondent has which is in line with current evidence based 
knowledge. Study population averages of the number of correct answers will be noted. The 
data will then be refined and examined for associations and connections, including 
assessing differences in the knowledge, attitudes and perceptions of providers and patients 
by sex and age group. Prescribing behaviour will be assessed by identifying differences in 
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the number of correct prescribing answers and looking for associations with the number of 
consultations per day. Patient expectations will be assessed through the prescriber answers, 
as well as the self-reported patients’ answers. Associations will be examined between 
patient education level and answers to the knowledge questions, associations with patient 
behaviours will also be examined. Associations will be tested for significance using T-tests, 
Wilcoxon rank sum tests, Kruskal Wallis tests and multivariate logistic regression models. 
Testing methods will vary depending on normality of data. This analysis plan will enable the 
primary and secondary objectives of this study to be met. 
Risks and Benefits 
The original project has received approval from the Human Research Ethics Committee; the 
approval number is HREC REF: 610/2015. Individuals participating in the project were 
treated equitably and fairly. The major risks in the primary project were that patients and 
prescribers may feel uncomfortable with the questions asked in the survey. This could cause 
them to feel like they are not well educated in regards to antibiotic use and resistance. 
Prescribers could feel that their knowledge is being tested, and could feel frustrated by this. 
These risks were minimised by ensuring that respondents knew that participation in the 
survey was voluntary and anonymous; no identifying demographic data was collected. The 
principle of justice was upheld by ensuring those who shared in the risks of the project, 
shared in the post-study benefits.  
The main benefits of the project to respondents, is that participants could through the 
survey, find out that they needed to learn more about correct antibiotic use and ABR. To 
ensure beneficence, benefits of the study for participants were maximised by making any 
interventions planned due to the study, available to respondents and information regarding 
the results will be sent out using the same networks as used during recruitment. Society will 
benefit from this research by being able to plan interventions based on evidence, to ensure 
that ABR can be slowed down. This project will further the knowledge base of this issue, and 
allow for a better understanding of antibiotic knowledge, attitudes and perceptions in the 
South African context.  
Informed Consent Process 
Informed Consent was obtained during the original project from each participant prior to 
participating in the survey and, in the case of the online version, was integrated into the 




Privacy and Confidentiality 
Participants in the study will be treated fairly and equitably. Privacy and Confidentiality are of 
utmost importance during the project and all completed surveys were anonymous and so a 
Patient Identification Number was allocated to each participant, names or other identifying 
data were never requested. All online surveys and collated data will be stored in a password 
protected file and paper surveys will be stored in a locked cabinet, both of which only the 
research staff can access.  Paper and online data will be stored for 5 years and then 
destroyed, by shredding the paper surveys, and deleting all electronic files, as well as 
emptying the recycle bin. Although the results of this study may be published, no information 
that could identify any of the participants will be included. There was no reimbursement for 
participants for participating in the primary study. 
Limitations 
There are several limitations to this project, these include recruitment method. Convenience 
and snowball sampling have limitations in that it has the possibility of not being 
representative, generally the same types of respondents are included when using this 
method and so variation in answers is limited, and results are not always generalizable. The 
sampling in the primary study focussed on private practice GPs and patients who presented 
at those practices. In order to gain a better understanding of the South African context, 
investigation will need to be done which focuses on prescribers and patients in the public 
health sector. By gaining an understanding of both sectors, a broader more generalisable 
picture will be able to be ascertained.  The urban only focus of the data collection is a further 
limitation of the study and further limits generalisability.  
Another limitation is that the surveys are self-reported. This opens up opportunities 
for bias, in terms of reporting and social desirability bias, where prescribers could state that 
they know more about ABR than they actually do, or that they prescribe only when 
completely necessary, when in reality this is not the case. Patients could report they comply 
with proper antibiotic use standards, and that they never pressurise GPs to prescribe 
antibiotics, when actual behaviours could be different. This limitation will be taken into 
consideration when analysing the data and writing up the final report.   
Write Up and Dissemination  
The Knowledge, attitudes and perceptions of antibiotic use and ABR is a growing area of 
concern internationally. Similar projects have been completed in other research locations, 
but this project will allow region specific evidence to be in South Africa. The potential users 
of results generated from this study are other researchers, government and non-
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governmental organizations and the communities who are researched themselves. We will 
aim to disseminate findings at internal and external meetings, and once the findings have 





Brooks, L. et al., 2008. Towards a better understanding of patients’ perspectives of antibiotic 
resistance and MRSA: A qualitative study. Family Practice, 25(5), pp.341–348. 
Clardy, J., Fischbach, M. a & Currie, C.R., 2009. Primer The natural history of antibiotics. 
Current Biology, 19(11), pp.437–441. Available at: 
http://www.sciencedirect.com/science/article/pii/S096098220900918X. 
Hadi, U. et al., 2008. Audit of antibiotic prescribing in two governmental teaching hospitals in 
Indonesia. Clinical Microbiology and Infection, 14(7), pp.698–707. Available at: 
http://dx.doi.org/10.1111/j.1469-0691.2008.02014.x. 
Hardy-Holbrook, R. et al., 2013. Antibiotic resistance and prescribing in Australia: Current 
attitudes and practice of GPs. Healthcare Infection, 18(4), pp.147–151. 
Hawkey, P.M., 1998. The origins and molecular basis of antibiotic resistance. BMJ (Clinical 
research ed.), 317(7159), pp.657–660. 
Hawkings, N.J., Wood, F. & Butler, C.C., 2007. Public attitudes towards bacterial resistance: 
A qualitative study. Journal of Antimicrobial Chemotherapy, 59(6), pp.1155–1160. 
Kotwani, A. et al., 2012. Irrational use of antibiotics and role of the pharmacist: An insight 
from a qualitative study in New Delhi, India. Journal of Clinical Pharmacy and 
Therapeutics, 37(3), pp.308–312. 
Levy, S.B., 1998. The Challenge of Antibiotic Resistance. Scientific American, 278(3): pp 46-
53.  
McCullough, A.R., Parekh, S., et al., 2015. A systematic review of the public’s knowledge 
and beliefs about antibiotic resistance. Journal of Antimicrobial Chemotherapy, 71(1), 
pp.27–33. 
McCullough, A.R., Rathbone, J., et al., 2015. Not in my backyard: A systematic review of 
clinicians’ knowledge and beliefs about antibiotic resistance. Journal of Antimicrobial 
Chemotherapy, 70(9), pp.2465–2473. 
O’Neill, J., 2014. Antimicrobial Resistance : Tackling a crisis for the health and wealth of 
nations. Review on Antimicrobial Resistance, (December), pp.1–16. 
Spencer, B., 2003. The True History. Biomedical Scientist, 80(March), pp.246–249. 
Tonkin-Crine, S., Yardley, L. & Little, P., 2011. Antibiotic prescribing for acute respiratory 
tract infections in primary care: A systematic review and meta-ethnography. Journal of 
Antimicrobial Chemotherapy, 66(10), pp.2215–2223. 
WHO, 2014. Antimicrobial resistance. Bulletin of the World Health Organization, 61(3), 








Part B: Structured literature review 
Introduction 
Antibiotic resistance (ABR), also known as antimicrobial resistance has been labelled as the 
next big global health threat. ABR is driven by over use, over prescription and non-
adherence. ABR is not something that can be stopped, but it can be slowed down by 
understanding patients’ and prescribers’ knowledge, attitudes and perceptions of antibiotic 
use and resistance, and tailoring interventions around these. This literature review will 
explore findings from different studies on patients’ and prescribers’ knowledge, attitudes and 
perceptions of ABR as well as antibiotic use and prescription.  
The projects discussed in this review fall within the context of a global health care 
web, where interlinkages are complicated and global standards and communication 
networks are not always highly functional. If ABR continues spreading at current rates, it will 
soon outweigh effective treatment options. This will mean thousands of deaths due to 
pathogens which are considered treatable today. ABR is a naturally occurring phenomenon, 
where bacteria develop and change to ensure their survival by becoming resistant to the 
antibiotics used to treat them. This means that the more antibiotics are used, the quicker 
resistance occurs. Figure B1 below illustrates how the use of antibiotics produces 
resistance. 
 
Figure B1 from (MeMed 2016) 
 
The Centers of Disease Control and Prevention (CDC) reported that in the USA, 2 
million people become infected with resistant bacteria each year, and 23 000 people die as a 
result of these resistant bacterial infections (CDC 2016). A recent modelling project on the 
impact of resistance revealed that by 2050 ABR will cost the world up to 100 trillion USD and 
10 million people will die each year as a direct result of ABR if effective prevention programs 
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are not put in place (O’Neill, 2016) to slow resistance down. As can be seen in Figure B2 
below, the majority of these deaths will be in Asia (4 730 000) and Africa (4 150 000). The 
WHO (2016) has listed many concerns about resistance; these include poor surveillance, 
under reporting and the massive financial and human resource burden that ABR will place 
on health care systems. ABR was the focus of a United Nations General Assembly meeting 
in September 2016, the 4th time in the history that a health topic has been the focus of such 
a meeting, showing the seriousness with which this issue is viewed (Mendelson et al. 2016). 
There is limited information on the extent of ABR in Africa as surveillance is only carried out 
in a handful of countries (WHO 2014).  
 
Figure B2 from (O’Neill 2014) 
 
 
Antibiotics have become less effective as a result of rising resistance levels and no 
new antibiotic classes have been developed since the 1980s.This means that resistance will 
rapidly outpace available treatment options (WHO 2014) and a global crisis will ensue. In 
order to slow down ABR, antibiotics should only be prescribed and used when absolutely 
necessary (Levy 1998). A further major use of antibiotics (which is not the primary focus of 
this literature review, but needs to be mentioned) is the use of antibiotics in animal 
husbandry. One use, which has been banned in some countries, is the addition of growth 
promotors to animal feed which has an unquantifiable impact on resistance levels (Hawkey 
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1998). The use of antibiotics in animal husbandry needs to be optimised and monitored in 
order to ensure best practices are followed which will minimise impacts on ABR.   
 
Objectives 
The objective of this literature review is to summarise and discuss the available evidence on 
knowledge, attitude and perceptions of antibiotic resistance and antibiotic use. This review 
will enable the author to assess what literature is available to assist in assessing the four 
main objectives of the study as follows: 
Knowledge about antibiotic use and resistance will be assessed so that a clear 
understanding of local and global knowledge on correct antibiotic prescribing behaviour can 
be gained, as well as an understanding of what patients know about how and when to use 
antibiotics, and about both patients’ and prescribers’ knowledge around ABR. This will be 
helpful in assessing where there are gaps in knowledge in both groups, which could be 
beneficial for potential intervention planning.  
Attitudes towards antibiotic use and resistance will be assessed to see what other 
studies have found in varying parts of the world. Attitudes regarding use and resistance are 
very important in terms of slowing down ABR. Literature on this facet could offer insight into 
potential global attitude patterns.  
Perceptions of ABR and use will also be assessed to try and locate the reasons 
behind harmful behaviour, as negative attitudes which lead to negative behaviours are often 
based on incorrect perceptions. The review hopes to identify these incorrect perceptions, 
which could shed some light on the global situation and which will assist in placing the South 
African respondents in this study into a global context.  
Associations between knowledge, attitudes and perceptions will then be assessed, to 
see what patterns emerge, and if any clear overlaps can be seen. If patterns emerge from 
the literature that illuminate these incorrect perceptions, there is the potential to intervene 
and change both perceptions and attitudes, by improving knowledge on these issues, and 
this will hopefully lead to behaviour change which will slow down resistance.   
Conceptual Framework 
It is hypothesised that poor antibiotic use and resistance knowledge, attitudes and 
perceptions leads to destructive antibiotic use which leads to increased resistance as 
illustrated in Figure B3 below. This project is assessing these facets in order to better 











Search Strategy  
A search of primary studies and reviews was conducted on the PubMed, Medline and 
Cochrane databases. The search strategy used the terms detailed in Table B1 below. The 




Full text papers published in English, from 1990 – 2016 were included. Included studies 
focussed on the knowledge, attitudes and perceptions of patients and prescribers around 
antibiotic use, behaviours and resistance, as this was the focus of the planned study. 
Studies evaluating prescribing practices were excluded as this was not the focus of the 
study. Only papers showing research in humans were included. Systematic reviews and 
observational studies from high, middle and low income countries were included in order to 
get a global understanding of the topic. A quality assessment of included studies was made 
by reviewing the methods section of each paper. Outcomes of studies were extracted and 
data was placed in the table of results (below). These results are then discussed and 
general patterns that emerged are described.  
Results 
Patients’ and prescribers’ knowledge, attitudes and perceptions around antibiotic use and 
resistance vary but there are several commonalities. The majority of prescribers know ABR 
is a major issue but many feel pressure to prescribe antibiotics when not absolutely 
Table B1- Electronic Search Strategy 
#1 "Drug Resistance, Microbial"[Mesh] 
#2 (PubMed) ("Anti-Bacterial Agents"[Mesh] AND "Drug Resistance, Microbial"[Mesh]) AND ("Knowledge"[Mesh] OR "Perception"[Mesh] OR 
"Attitude"[Mesh]) AND ("Patients"[Mesh] OR "General Practitioners"[Mesh]) 
#3 “antibiotic resistance” OR  “perception” OR “attitudes” OR “knowledge” 
#4 “ABR” OR “antimicrobial resistance” OR “AMR” AND  “perception” OR “attitudes” OR “knowledge” 
#5 “antimicrobial resistance” AND  “perception” OR “attitudes” OR “knowledge” 












necessary. Many patients believe the human body (rather than the microbial organism) 
becomes resistant to the antibiotics, and are not aware of the full scale of the issue, and 
think scientists can develop new antibiotics. These findings and others are detailed in Table 
B2 below.  
Table B2- Details of Findings  




Knowledge, Attitude, Perceptions of Antibiotic Use and 
Resistance 




Hoffmann, & Del 
Mar, 2015  
Systematic 
review including 





Prescribers  98% believe resistance is a serious problem, 67% believe it is a problem in their 
practice, and 89% believe it is a problem globally. 97% stated resistance was 
caused by excessive antibiotic use, and 90% stated non-adherence. Some 
individual studies listed in this review were also included in this systematic review.   
Tonkin-Crine, 








tract infections  
GPs are aware of ABR, but feel pressure to prescribe antibiotics in order to pacify 
patients. In order to ensure acceptability of interventions, GPs should reflect on 
their own prescribing; management options must be clear, education is necessary, 












Fourteen studies found a direct relationship between complacency and 
misprescription, two studies found no relationship. Seven studies found a direct 
relationship between fear and misprescription. Direct relationship between health 
care burden and misprescribing in seven studies, and no relationship in 6 studies. 
Two studies found a direct relationship between the pressure exerted by the 
pharmaceutical industry on prescribing, and two studies found no relationship. 
Kenealy, Arroll, 




Not stated Prescribers  Just under 1.2 million people are estimated to be prescribed antibiotics when first 
presenting with a common cold and acute purulent rhinitis. Participants receiving 
antibiotics did not get better more quickly, and symptoms were not less severe. If 
these antibiotics were not initially prescribed, a total average saving estimated to 
be £3.3 million. 
 
Arnold 2009 Systematic 
Review 





The effectiveness of an intervention on antibiotic prescribing depends to a large 
degree on the particular prescribing behaviour and the barriers to change in the 





Cross sectional 26 countries 
in Europe 
Outpatient care 
givers   
Prescription of antibiotics in primary care in Europe varied greatly; the highest rate 
was in France (32.2 defined daily doses per 1000 inhabitants) and the lowest was 
in the Netherlands (10 defined daily doses per 1000 inhabitants). 
Gulliford et al., 
2014 





treating adults (18 
– 59 year olds) 
with respiratory 
tract infections 
Most UK general practices prescribe antibiotics to young and middle-aged adults 
with respiratory infections at rates that are considerably in excess of what is 
clinically justified. The median general practice prescribed antibiotics at 54% of 
respiratory tract infections (RTI) consultations (90 percentile- 69% of RTI 
consultations, 10th percentile-39% of RTI consultations). 
Lee et al., 2014 Cross sectional USA Prescribers to 
outpatients 
1.4 billion antibiotics dispensed from 2000 – 2010 to outpatients. Rates of broad 




Dewindt, & Dinh, 
2013 
Cross sectional Australia 730 General 
Practitioner (GPs) 
40% of respondents stated they would prescribe antibiotics to meet patients’ 
expectations. 50% of prescribers said they discussed antibiotic resistance with 
patients. 
Abera, Kibret, & 
Mulu, 2014 
Cross sectional Ethiopia Physicians and 
nurses 
65% of physicians and 98% of nurses replied that they need training on 
antimicrobial stewardship. The two most important factors mentioned for ABR 
development were patients’ poor adherence to prescribed antimicrobials (86%) 





Dallas et al., 
2015 







Antibiotics were prescribed in 21.6% of encounters for upper respiratory tract 
infections (URTI) and 73.1% of encounters for acute bronchitis/ bronchiolitis. GP 
trainee antibiotic prescribing is higher than justified by guidelines. 













Antibiotics were given to 84% of patients included in the study (834 of 999). 
Approximately 60% of prescriptions were classified as incorrect, either unjustified 
or inappropriate.  
 
Mustafa, 2014 Qualitative  South Wales, 
UK 
Family physicians URTI consultations are sources of potential conflict, especially when patients 









Prescribers thought ABR was more of a problem nationally (92%) than in their own 




Qualitative India Pharmacists Understocked pharmacies- pharmacists can only dispense part of a prescription, 
and poor patients cannot afford to come back. Overstocked pharmacies- 
overprescribing occurs. Even though unqualified, most participants admitted to 
prescribing antibiotics for diarrhoea, common cold, mild fever, sore throat and 
cough. 















Patients  70% of participants had heard of the term antibiotic resistance, 88% believed the 
person becomes resistant to antibiotics, 53% believed resistance was a problem in 
their country. 70% believed ABR was due to excessive or unnecessary (74%) 
antibiotic use. Some individual studies listed in this review were also included in 
this systematic review.   
Gebeyehu, 
Bantie, & Azage, 
2015 




30.9% of all antibiotic use was inappropriate. RTI symptoms (74.6%), diarrhoea 
(74.4%), and physical injury/wound (64.3%) were the three main reasons that the 
communities had used antibiotics inappropriately. 36% of all participants, 46.4% of 
urban and 30.6% of rural, had taken antibiotics in the past one year prior to the 
study period. 
El Zowalaty et 
al., 2016 




63.6 % of participants reported to have purchased antibiotics without a prescription 
from pharmacies, 62% of respondents who used drugs without prescription agreed 
with the statement that antibiotics should be access-controlled. The overall level of 













Surveys done after campaigns showed that those exposed to the campaigns were 
more likely to agree with standards of appropriate use of antibiotics and were less 
likely to expect antibiotics. After campaigns most doctors reported prescribing 
antibiotics less frequently than before (66% of doctors in France- 66%, Belgian- 
63%). Educating the public about the differences between infections caused by 
viruses or bacteria seems difficult. In France, after successive campaigns over 5 
years, 54% of the public still did not know that most upper RTIs are of viral origin 
and do not need treatment with antibiotics.  
Sanya, Fakeye, 
Adisa, & Segun, 
2013 
Cross sectional Nigeria Non-medical 
undergraduate 
students 
 68% obtained their antibiotics through doctor’s prescriptions, Financial constraints 
(73; 18.3%), long duration of treatment (70; 17.5%), side effects experienced 
(60;15.0%), polypharmacy (56;14.0%), tablet size (45;11.3%), and perceived low 
level of confidence in the prescriber (11; 2.8%) were major reasons for non-
adherence. 
Hounsa, 
Kouadio, & De 
Mol, 2010 
Cross sectional Côte d’Ivoire Customers of 
pharmacies 
Among 1,123 purchases of antibiotics 242 (21.5 %) were for self-medication. Out 
of the 1,765 people interviewed, 1,054 (59.7 %) had bought antibiotics for self-










79% stated that diseases caused by bacteria can be treated with antibiotics but 
24% of these also said that antibiotics can be used for treating viral disease. Most 
(85%) said that sexually transmitted infections (STI) can be treated with antibiotics 
while 1% said the same about headache, 4% general weakness and 3% ‘all 

















53.1% of those contacting their GP about the infection expected an antibiotic 
prescription. Of the 452 (26%) responders who reported asking their GP or nurse 
for antibiotics in the past year, only 3.5% were refused them, 74% were prescribed 
antibiotics after some discussion and 23% without any discussion about their 
illness. 24% of respondents believed that antibiotics work on most coughs and 
colds, and 38% reported believing that antibiotics can kill viruses.  
Brookes-Howell 





Parents of children 
with respiratory 
tract infections 
79% (50 of 63) of parents accepted prescribing behaviour, regardless of antibiotic 
prescription. 20% (13/65) of parents disagreed with prescribers when they did 
prescribe antibiotics, whereas 4.6% (3/65) disagreed when antibiotics were not 
prescribed.  
Hawkings, 
Wood, & Butler, 
2007 
Qualitative Wales 46 patients aged 
18 – 89 years old 
87% of participants blamed GPs for over prescribing antibiotics. 24% stated poor 
hospital hygiene was thought to be the cause of resistance. 4 % stated resistance 
was cause by use of antibiotics in animals, and 3% stated it was because of 
antibiotic use in other countries. 
Jin, Ely, Fang, & 
Liang, 2011 
Qualitative China (rural) Patients Patients can buy antibiotics freely from the pharmacies without prescription 
although this has formally been officially forbidden since 2004. The majority of 
participants believed the human body developed resistance to antibiotics. 
Brooks, Shaw, 
Sharp, & Hay, 
2008 
Qualitative Not stated Primary care adult 
patients  
Many primary care patients are unaware of what antibiotic resistance is and how it 
arises. Patients are uncertain of antibiotic resistance and methicillin resistant 
Staphylococcus aureus (MRSA) were. Patients believe that controlling resistance 
is out of their control.  
 
Discussion 
The table above outlines individual studies and some systematic reviews on the topic. As 
can be seen in the table, patients’ and prescribers’ knowledge, attitudes and perceptions 
differ over geographical areas, but there are certain commonalities. Stark contrasts can be 
seen between prescribers and patients understanding of ABR, the causes of resistance are 
often placed on the other party, and very little clear communication on the subject occurs 
between the two.   
 Prescribers’ knowledge, attitudes and perceptions 
Prescribers showed an understanding that ABR is a big issue. A systematic review reported 
that 98% of providers believed it was a serious problem, and approximately 90% of providers 
stated it was a global (McCullough et al., 2015) or national (Brinsley et al. 2005) issue. 
However considerably fewer providers considered it to be a local concern with 76% 
identifying it as an issue in their own institution (McCullough et al., 2015) and <70% in their 
own practice (Brinsley 2005; McCoullough et al 2015) . The title of the systematic review by 
McCoullagh et al. (2015) is therefore apt, Not In My Backyard (McCullough, Rathbone, et al. 
2015).  
Many prescribers attributed increasing ABR levels to patients not adhering to 
treatment (McCullough et al., 2015). Abera et al. (2014), reported that 86% of respondents 
stated that poor adherence was the cause of ABR (Abera et al. 2014). A further reason given 
by respondents for ABR was excessive antibiotic use, e.g. 97% in the review by McCullough 
et al. (2015) and 80% in a cross-sectional study in Ethiopia (Abera et al. 2014). 
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Nevertheless, few prescribers drew the link to themselves, in terms of prescribing behaviour 
which is an identified gap that would be a useful focus of interventions.   
Poor prescribing behaviours can be seen in many of the papers including in the 
McCullough review (2015); antibiotics are often prescribed when unnecessary, unjustified, 
incorrect or inappropriate. Kenealy et al. showed that 1.2 million people are estimated to be 
prescribed antibiotics when first presenting with a common cold and acute purulent rhinitis, 
and that those who took antibiotics did not get better quicker, and their symptoms were not 
less severe  (Kenealy et al. 2013). Guilliford et al. showed that most United Kingdom (UK) 
general practices prescribe antibiotics to young and middle-aged adults with respiratory 
infections at rates that are considerably in excess of what is clinically justified (Gulliford et al. 
2014). Lee et al stated that rates of broad spectrum antibiotic prescriptions doubled from 
2000 to 2010 (Lee et al. 2014), which could partially be explained by the expectations and 
pressure patients place on prescribers (Tonkin-Crine et al. 2011) (Mustafa 2014), as shown 
in one study where 40% of respondents stated they would prescribe antibiotics to meet a 
patients’ expectations (Hardy-Holbrook et al. 2013). An Indonesian study showed that 60% 
of prescriptions were classified as incorrect, either unjustified or inappropriate (Hadi et al. 
2008), and a UK study showed that GP trainees prescribe antibiotics at rates higher than 
justified by guidelines (Dallas et al. 2015). The Lopez et al. systematic review and Kotwani et 
al study (2012) reported relationships between misprescription of antibiotics and 
complacency, fear, health care burden and pressure exerted by the pharmaceutical industry 
(Lopez-Vazquez et al., 2012; Kotwani et al, 2012). These behaviours have negative 
consequences in terms of ABR, and also cost health care systems (and sometimes 
individual patients) a lot of money. For example, Kenealy et al, show that a total average 
saving estimated to be £3.3 million would occur if unnecessary antibiotics were not 
prescribed (Kenealy et al, 2013).  
Little or no communication between prescribers and patients seemed to occur on the 
topic, and this was not seen as a priority by prescribers. For example, the McCoullough 
review shows that one of the main intervention strategies suggested by patients is to discuss 
ABR with their clinicians, however only 36% of respondents had ever discussed ABR with 
their doctor (McCullough et al 2016). A further study showed that only 50% of prescribers 
had discussed ABR with their patients (Hardy-Holbrook et al, 2013). This shows a niche 
opening for potentially effective interventions which should focus on self-efficacy.  
All of these factors make the issue of ABR a complex one. Prescribers’ knowledge, 
attitudes and perceptions cannot be looked at in isolation, as patients’ roles in all of the 
above are crucial. 
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Patients’ knowledge, attitudes and perceptions 
The McCullough et al. review reported that 70% of patients had heard of antibiotic resistance 
but only half believed it was a problem in their own country (McCullough et al. 2016). The 
majority of respondents believed that antibiotic resistance occurs when the human body (Jin 
et al, 2011) rather than the microbial organism becomes resistant to the antibiotics; 88% of 
respondents reported this belief in the McCullough et al review (2016). 24% of respondents 
in the Viberg et al study stated that antibiotics could be used to treat viral infections (Viberg 
et al, 2010), as did 54% of respondents in the Huttner study (Huttner et al. 2010). There was 
a clear difficulty in the explanation of the difference in treatments for bacterial and viral 
infections, which led to some confusion about antibiotic use (Viberg et al, 2010).  
Some patients had an accurate view of the causes of resistance,74% of respondents 
in one study stating that the reason for ABR was excessive and unnecessary antibiotic use 
(McCullough et al, 2016). Many of those who did know about resistance stated that they had 
no control over ABR levels (Brooks et al. 2008), and placed the blame for its occurrence on 
GPs and other prescribers, stating that they should not overprescribe (Hawkings et al. 2007). 
Patients did however acknowledge behaviours which are seen as harmful in terms of ABR. 
These behaviours include pressuring prescribers to prescribe antibiotics when not absolutely 
necessary (Brooks et al 2008 ; McNulty et al, 2013), self-medicating with antibiotics (Hounsa 
et al., 2010; El Zowalaty et al., 2016; Gebeyehu et al., 2015), purchasing antibiotics without 
prescriptions (El Zowalaty et al. 2016) and not following instructions for adherence to 
treatment with antibiotics (Sanya et al. 2013). Reasons for non-adherence were financial 
constraints, long duration of treatment, side effects experienced, tablet size and perceived 
low level of confidence in the prescriber (Sanya et al. 2013). 
Antibiotic use rates were self-reported as high. A third of respondents in an Ethiopian 
study had taken antibiotics in the 12 months prior to the interview; 30% of this use was 
deemed inappropriate (Gebeyehu et al. 2015). 60% of respondents in the Hounsa et al. 
study had reported buying antibiotics for self-medication purposes in the last 12 months 
(Hounsa et al. 2010). These behaviours show possibilities for interventions. 
 
Interventions 
Interventions are needed in order to slow down ABR. Tonkin-Crine et al stated that 
prescribers should reflect on their own prescribing behaviours in order to ensure any ABR 
interventions were effective (Tonkin-Crine et al. 2011). Education programs and 
standardised treatment courses were suggested by many prescriber participants in these 
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studies, such as in the Abera et al. study where 65% of physicians and 98% of nurses stated 
they needed training (Abera et al. 2014). The effectiveness of educational programs was 
confirmed in the Huttner study which showed that education campaigns have a positive 
impact on patients’ behaviours, and that patients were less likely to use unnecessary 
antibiotics if the ramifications had clearly been explained to them (Huttner et al. 2010). Due 
to education programs, patients became more accepting of the standard course of treatment 
(Huttner et al. 2010). This decreased the pressure placed on GPs to prescribe, and this 
could assist in decreasing the amount of unnecessary consumption of antibiotics. 66% of 
French GPs and 63% of Belgian GPs who were a part of the Huttner et al. study self-
reported prescribing antibiotics less frequently after educational campaigns were run, but the 
same study found that educating the public about the differences between infections caused 
by viruses or bacteria was difficult (Huttner et al. 2010). These education programs need to 
be paired with other solutions and more rigorous research methods need to be implemented 
to test the effectiveness of these interventions as self-reporting can introduce bias. 
A novel approach, and a major achievement in terms of finding solutions to this crisis, 
has been the formation of the New Drugs for Bad Bugs programme. This is a private public 
partnership with €650 million being invested across seven projects ranging from basic 
science to drug discovery, and the development of new business models all attempting to 
curb resistance (Matthiessen et al. 2016). Another collaborative effort is the formation of the 
Global Antimicrobial Conservation Fund which will provide capacity building financial and 
technical support. More surveillance funding is necessary in order to monitor the growing 
global spread of resistance. Along with this fund, a mass global education campaign is 
needed (Mendelson et al. 2016).   
 
Limitations 
There were several limitations of this review, one being the generalisability of studies found 
to the South African context, several biases in the studies, and the fact that very few 
associations were mentioned between knowledge, attitudes and perceptions. 
The majority of the studies were from high income regions, and very few papers 
covered low and middle income settings. This makes a comparison to the South African 
context difficult, as the findings from the majority of the studies may not be generalizable to 
the South African context.   
 There was potential bias in some surveys. Recall bias is a possibility for those 
surveys that relied on self-reporting  (Tonkin-Crine et al., 2011; Gulliford et al, 2014; Hardy-
Holbrook et al., 2013; Dallas et al., 2015). Social desirability bias could also have been an 
issue as GPs may not have been honest about overprescribing to patients (McCullough et 
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al., 2015; Tonkin-Crine et al., 2011; Hardy-Holbrook et al., 2013), while patients may not 
have been honest about demanding antibiotics or other harmful behaviours (McCullough et 
al., 2016; El Zowalaty et al., 2016), and could be more likely to give positive answers on 
future behaviours (Huttner et al. 2010). 
  As not all the studies conducted used randomised sampling techniques, the people 
who ended up being respondents could be those who were more likely to have good 
prescribing habits, or who were more knowledgeable about ABR, all of which would 
introduce non-response bias and skew results. Fifty four percent of the 54 studies of 
patients’ knowledge, attitudes and perceptions included in the McCoullagh review (2016) 
had high response rates and 34% had moderate response rates (McCullough et al. 2016).  
Among the 57 papers assessing clinicians’ knowledge, attitudes and perceptions in a review 
by the same authors, a third had high, a third medium, and third low response rates 
(McCullough, Rathbone, et al. 2015). 
Not many studies reviewed the associations between knowledge, attitudes and 
perceptions which is a further limitation of this review. The El Zowalaty study showed 
statistically significant associations between knowledge and gender, age and education (El 
Zowalaty et al. 2016), but associations between knowledge, attitudes and perceptions were 
not clear. The McCoullagh review did mention a knowledge gap whereby clinicians showed 
confusion about the duration of ABR which impacted upon prescribers’ behaviours 
(McCullough, Rathbone, et al. 2015), but other associations did not seem to be explored.  
The sample size in most of the studies was acceptable, the biggest were the 
McCoullough reviews, which included 11 593 clinicians (McCullough, Rathbone, et al. 2015) 
and 55 225 patients (McCullough et al. 2016).  
 
Conclusion 
The key findings of the review are that even though both patients and prescribers exhibit 
harmful behaviours that speed up ABR, they blame each other for the crisis. There is very 
little communication about the issue between the two parties, and the severity of the issue is 
not taken as seriously as it should be. Resistance is seen as a problem that occurs outside 
respondents’ practices, or lives, or beyond their borders. The global nature of the issue 
seems to be lost. 
Little is known about patients’ and prescribers’ knowledge, and attitudes and 
perceptions in the South African context. More information is needed in order to best plan 
interventions which can slow ABR down globally and in different local contexts. This need 
leaves a gap which this research project can fill, and it will add to the scant body of evidence 
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around patients’ and prescribers’ knowledge, attitudes and perceptions on ABR and 
prescribing behaviour in South Africa.  
Understanding the local context is imperative in order to participate in the global fight 
against ABR, and the first step needs to be to ascertain how big the issue is in the local 
context, and what the current knowledge and plans are around trying to combat the issue. 
This project will not focus on ascertaining the breadth or depth of the resistance issue, but 
will focus on gaining an understanding of local prescribers’ and patients’ knowledge, 
attitudes and perceptions. This project will yield unique South African based insights into 
antibiotic prescribing, ideas about ABR, and insights into patients’ and prescribers’ 
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Background: Antibiotic resistance (ABR) may be the next global health crisis. We aimed to 
describe South African patients’ and prescribers’ ABR knowledge, attitudes and perceptions 
(KAP).   
Methods: We conducted a cross-sectional KAP survey among a convenience sample of 
prescribers and patients in South Africa. We used logistic regression to examine 
associations between knowledge and antibiotic use, beliefs, or behaviours.  
Findings: Mean patient (n=403) knowledge scores (out of 14) were higher in females 
(p=0.0005) and those with more education (p=0.015);76% believed the human body 
becomes resistant. After adjusting for education and sex, a 1-unit increase in knowledge was 
associated with increased odds of the following beliefs: (i) important to finish the antibiotic 
course (aOR 1.34; 95% CI:1.16, 1.66); (ii) over use impacts ABR (aOR 1.3; 95% CI:1.18, 
1.43) but reduced odds of (iii) demanding antibiotics should be given (aOR 0.84; 95% 
CI:0.74,0.94); (iv) feeling relieved (aOR 0.89; 95% CI:0.81, 0.97) or happy (aOR 0.905; 95% 
CI:0.82, 0.99) when prescribed antibiotics.  
Prescribers (n=175) >55 years old had lower median knowledge scores (p=0.0005). 
Those who infrequently prescribe antibiotics when unnecessary had higher knowledge 
scores (p=0.01);70% feel pressure from patients to prescribe antibiotics.  
Prescribers with higher knowledge scores were more likely to believe the following: 
(i) to decrease ABR, narrow spectrum antibiotics should be used (aOR 1.41; 95% CI:1.03, 
1.92), (ii) explaining to patients disease features which should prompt follow up (aOR 1.76; 
95% CI:1.01, 30.74). Prescribers with higher knowledge scores were less likely to report that 
antibiotics cannot harm the patient if they are not needed so they prescribe when not 
necessary (aOR 0.55; 95% CI: 0.33, 0.91). 
Conclusion: The association between knowledge and behaviour/perceptions suggests that 




Antibiotic resistance (ABR) (alternately known as antimicrobial resistance) has been 
labelled a major health threat by the World Health Organisation (1). Currently 700 000 
people die a year from ABR. By 2050, ABR will cost the lives of 10 million people a year if 
solutions are not followed to slow down its course (2). ABR occurs when bacteria become 
resistant to treatment by antibiotics (3) .This means that bacteria that cause common, 
currently easy to treat illnesses are becoming resistant to treatment options. Morbidity and 
mortality from these diseases could increase. The lifespan of all antibiotics is limited (1); the 
initially produced antibiotics which brought in the golden age of health care are now largely 
ineffective (4). Effective new antibiotics have not been produced since the 1980s (5).  
ABR is accelerated by the over prescription and misuse of antibiotics (1). Rates of 
broad spectrum antibiotic prescriptions in the USA doubled from 2000 to 2010 (6) . An 
Indonesian study showed that antibiotics were given to 84% of patients included in the study 
and approximately 60% of the prescriptions were classified as incorrect, either unjustified or 
inappropriate (7). A systematic review of 57 studies found that 98% of prescribers think that 
ABR is a serious problem but only 67% believe it is a problem in their own practices (8) .  
Patients also believe ABR is a problem in their country, and 88% believe the human body, 
rather than the microbial organism, becomes resistant to the antibiotics (9) .  
There is limited communication between patients and prescribers on the topic (10). 
This lack of understanding of the ramifications of overuse could be a potential cause of 
overprescribing as prescribers often feel pressurised to prescribe antibiotics due to patient 
requests and expectations (11), which leads to unnecessary use of antibiotics. Another 
systematic review found direct relationships between complacency, fear, health care burden 
and harmful prescribing behaviours (12). Seventy-four percent of respondents who asked for 
an antibiotic were prescribed one in a United Kingdom (UK) based study (13). Patients’ lack 
of understanding of the true causes of ABR and not understanding their role in controlling 
ABR will decrease the effectiveness of intervention programs. One study showed that 87% 
of participants blamed ABR on general practitioners for over prescribing antibiotics (14);  
patients may feel that limiting ABR is out of their control (15).  
There is a dearth of literature on ABR levels in Africa; there are limited surveillance 
programs (5), and not much monitoring of prescribing behaviours. Poor knowledge and 
understanding of ABR can lead to harmful antibiotic use and prescribing behaviours such as 
over using antibiotics, relying on broad spectrum treatments and taking antibiotics when not 
absolutely necessary, which then leads to increased ABR levels. The purpose of this study is 
to assess the knowledge, attitudes and perceptions of patients and prescribers in the private 
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health care setting in South Africa on antibiotic use and resistance in order to gain insight 
into possible interventions to effectively slow down ABR.  
 
Methods 
This study obtained ethical approval from the University of Cape Town Human Ethics 
Research Committee (HREC REF: 722/2016), and is an analysis of data collected during a 
cross sectional study (HREC REF: 610/2015) between October 2015 and December 2016. 
The survey was conducted among patients visiting General Practitioner (GP) practices and 
prescribers (GPs and Nurses) in health care facilities using a convenience sampling 
approach. Hard copies of the survey as well as a link to complete the survey online were 
distributed to private GP practices and presented at a number of academic meetings. 
Patients were asked by reception staff at GP practices to complete the survey when they 
arrived for consultations. The survey questionnaire and categories were developed in 
conjunction with similar tools found in the literature and through discussion with colleagues. 
The completion of the survey was preceded by respondents signing an informed consent 
form. Online surveys were completed on SurveyMonkey and hard copy surveys were 
entered onto SurveyMonkey by research staff. Inclusion criteria were: (i) over the age of 18, 
(ii) patient or prescriber at a private health care facility in South Africa, (iii) able to provide 
informed consent, (iii) willing to participate in the study. No identifying information was 
collected from participants. 
Analysis was conducted using Stata 14. Descriptive statistics were used to show 
patterns about the attitudes and perceptions of respondents. Correct answers in the 
knowledge sections were used to assess the proportion of knowledge each respondent had 
which is in line with current evidence-based knowledge. Knowledge scores were calculated 
out of total number of questions answered by each participant and not the total number of 
questions in the survey. Knowledge scores for patients were normally distributed, and 
means and standard deviations are reported. Knowledge scores for prescribers were 
skewed, and medians and inter quartile ranges (IQR) are reported.  
Associations between knowledge scores and demographic characteristics of patients 
were tested for significance using t-tests, and for prescribers using Wilcoxon rank sum tests. 
Prescribers’ self-reported frequency of prescribing antibiotics was tested for association with 
knowledge scores using a Kruskal Wallis test. Associations between knowledge, attitudes 
and perceptions of patients and prescribers were explored in logistic regression models.  
Answers in the ‘unsure’ category of all behaviours/beliefs were grouped together with the 
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‘disagree’ category answers, to get a binary outcome. Logistic regression models for patient 
beliefs were adjusted a priori for sex and education, and models for prescriber beliefs were 
adjusted for age and type of practitioner (nurse or doctor). 
Results  
Demographic characteristics 
Among 403 patients who completed the survey, the largest age groups were 25 – 34 
years (n= 101, 27%) and 35 – 44 years (n= 92, 24%) and most (n=263, 72%) were female 
(Table 1). Fifty-four percent (n= 198) of patients’ highest qualification was the completion of 
secondary school. Among 175 prescribers who completed the survey, 98% were doctors; 
92% were solely from private practice. Many of prescribers (43%) were over the age of 55. 
Demographic characteristics are detailed in Table C1 below.  
Table C1- Demographics        
Patients (n=403)    Prescribers (n = 175)  
  Category n (%)                                     Category n (%) 
Age (years)  <25 32 (8%)   Age (years)  25 - 34 13 (8%) 
  25 - 34 101 (27%)     35 - 44 51 (32%) 
  35 - 44 92 (24%)     45 - 54 29 (18%) 
  45 - 54 72 (19%)     >55 70 (43%) 
  55 - 64 55 (15%)       
  >65 27 (7%)   Profession  Nurse 3 (2%) 
        Doctor 164 (98%) 
Sex  Female 263 (72%)       
  Male 102 (28%)   Practice Type  Public Sector 0 (0%) 
        Private Sector 152 (92%) 
Highest Level  Grade 1 - 8 5 (1%)     Both, mainly public 6 (4%) 
of Education  Grade 9 - 11 25 (7%)     Both, mainly private 7 (4%) 
  Secondary School 198 (54%)        
  University degree 93 (25%)        
  Post graduate 
degree 45 (12%) 
       
           
 
Knowledge Scores 
The knowledge scores of patients (n=403, 14 knowledge questions) and prescribers 
(n=175, 7 knowledge questions) are detailed in Figure C1 below. The mean knowledge 
score for patients was 9 (out of a maximum of 14, SD 3) and the prescribers’ median score 
was 5 (out of a maximum of 7, IQR 4, 6). All of the questions were correctly answered by 16 
(4%) patients and 34 (19%) prescribers; 2 (0.5%) patients and 1 (0.6%) prescribers 
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answered all of the questions incorrectly. The mean number of non-responsive participants 
per knowledge question was 11 patients (3%) and 37 prescribers (21%). 




Patient perceptions, attitudes and knowledge scores 
Most patient respondents (76%) believed that ABR is when the human body 
becomes resistant to antibiotics and 76% believed antibiotics treat bacteria. Eighty percent 
of patients believe that you should not have access to antibiotics without a prescription and 
43% believe new antibiotics will be discovered. Thirty-two percent have been to the doctor 
specifically for an antibiotic, 59% would be happy with advice on what to buy over the 
counter if the care provider told them they did not need an antibiotic and 58% felt worried 
when prescribed antibiotics, because they prefer not to take antibiotics unless absolutely 
necessary. 
Associations between patient knowledge scores and demographic characteristics are 
explored in Table C2 below. Statistically significant associations, at the chosen level of 0.05, 
were found between the sex of patients and mean knowledge scores (female=9, SD 3; 
male=8, SD 3; p-value 0.0005). Patients whose highest qualification was below secondary 
school had a lower mean knowledge score (8, SD 3) compared to those who finished 










Knowledge Scores  
Patient max 14, prescriber max 7 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
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score (Max 14) Std. Dev 
p value (t- tests) 
Sex  Female 263 9 3 
0.0005 
Male 102 8 3 
Age  Below 35 133 9 3 
0.39 
35 or Above 246 9 3 
Education 
Below secondary school 30 8 3 
0.015 
Above secondary school 330 9 3 
    After adjusting for education and sex, a 1-unit increase in patient knowledge score is 
associated with an increase in odds of having the following beliefs: finishing prescribed 
courses of antibiotics is important (aOR 1.34; 95% CI: 1.16, 1.6); overuse of antibiotics leads 
to body becoming resistant to antibiotics (aOR 1.17; 95% CI: 1.069, 1.29); antibiotics will 
work less well in future if we over-use them now (aOR 1.3; 95% CI: 1.18, 1.43) (Table 3). 
The following patient beliefs have a decrease in odds with every one unit of increase 
in knowledge score: If people demand an antibiotic, the doctor / nurse should give it to them 
(aOR 0.84; 95% CI: 0.74, 0.94); it is important to have antibiotics when one is very sick (aOR 
0.89; 95% CI: 0.82, 0.97); feeling of relief when prescribed antibiotics because doctor/nurse 
realises patient is sick (aOR 0.89; 95% CI: 0.81, 0.97); feeling happy when prescribed 
antibiotics because health care visit was justified (aOR 0.905; 95% CI: 0.82, 0.99) (Table 
C3). 
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Table C3- Logistic regression model with patients’ behaviours, attitudes and perceptions as outcome 
Outcome 
(Behaviour/perception) 
Adjusted OR* for 
effect of 1 unit 
increase in knowledge 
score 
95% CI p-value
It’s important for me to finish the course of antibiotics  I’ve been prescribed 
Agree 1.34 1.16, 1.60 <0.001 
If people demand an antibiotic, the doctor / nurse should give it to them 
Agree 0.84 0.74, 0.94 0.004 
When people take too many antibiotics their body becomes resistant to them 
Agree 1.17 1.069, 1.29 0.001 
Antibiotics will work less well in future if we over-use them now 
Agree 1.30 1.18, 1.43 <0.001 
Scientists will discover new antibiotics if the current ones stop working 
Agree 1.071 0.98, 1.16 0.103 
When I am very sick, it is important to have antibiotics 
Agree 0.89 0.82, 0.97 0.013 
When I tried simple remedies but they didn’t work,  it is important to have antibiotics 
Agree 0.94 0.86, 1.016 0.11 
I have been to the clinic specifically because you wanted an antibiotic for you or your child 
Yes 1.06 0.96, 1.15 0.20 
When prescribed antibiotics I feel relieved that the doctor/nurse realises I am sick 
Agree 0.89 0.81, 0.97 0.009 
When prescribed antibiotics I feel happy because my visit was justified 
Agree 0.905 0.82, 0.99 0.035 
When prescribed antibiotics I feel worried because I prefer not to take antibiotics unless absolutely necessary (Yes) 
Agree 1.069 0.97, 1.17 0.13 
*Adjusted for sex and education
Prescriber perceptions, attitudes and knowledge scores 
Ninety-eight percent of prescriber respondents stated that they believed antibiotics 
are overused in South Africa, 97% believe ABR is a big problem in South Africa and 70% 
feel pressure from patients to prescribe antibiotics. Thirty-two percent of prescribers will 
prescribe antibiotics half of the time if a patient expects an antibiotic but the prescriber does 
not think it is absolutely necessary, while 54% think other doctors prescribe antibiotics when 
they aren’t absolutely necessary. When respondents had prescribed antibiotics that were not 
absolutely necessary, the main reasons they gave was pressure from patients (42%) and 
that the patients could not afford laboratory tests (22%). Prescribers >55 years old had a 
lower median knowledge score (4.6, IQR 3.5, 5.8) compared to younger prescribers (5.6, 
IQR 4.7, 6; p=0.0005) (Table C4).  
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Table C4- Association of prescribers’ knowledge score and demographic characteristics (Wilcoxon 
Rank Sum Tests) 
N 
Median knowledge 
score (Max 7)  IQR 
P value 
Age  Below 55 93 5.6 4.7, 6 
0.0005 
55 or Above 70 4.6 3.5, 5.8 
Practitioner Doctor 164 5.25 4.2, 6 
0.78 
Nurse 3 4.75 3.5, 6 
 Number of Consultations Per Day 
Under 24 21 5 4, 6 
0.503 
Above 24 23 5 4, 7 
Table C5 below shows the median knowledge scores for prescribers who self-
reported prescribing antibiotics at differing frequencies when a patient expected them to but 
the prescriber felt they were not absolutely necessary. Knowledge scores were significantly 
associated with prescribing behaviours (p=0.01).  
 After adjusting for age and type of practitioner (nurse or doctor), a 1-unit increase in 
knowledge score was associated with an increase in odds of having the following behaviours 
and beliefs: narrow spectrum antibiotics should be used instead of broad spectrum 
antibiotics where possible (aOR 1.41; 95% CI: 1.03, 1.92); when antibiotics are not 
necessary, I explain to patients features which, if they develop, should prompt  them to seek 
further medical assistance (aOR 1.76; 95% CI: 1.01, 30.74) (Table 6). Those with higher 
knowledge scores were less likely to report that antibiotics cannot harm the patient if they 
are not needed so they prescribe when not necessary (aOR 0.55; 95% CI: 0.33, 0.908; 
pvalue 0.02) (Table C6). 
Table C5- Median knowledge scores for prescribers self-reported proportion of prescribing 
antibiotics when not absolutely necessary (Kruskal Wallis) 
Proportion of times prescribed 
antibiotics when not necessary
n Median Knowledge 
Score 
IQR p-value
Very often >90% 3 3 3, 5 
0.01 
Often >70% 10 4 3, 4 
About half the time  50% 54 4 3, 5 
Rarely <30% 65 4 3, 5 
Almost never <10% 38 5 4, 5 
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Table C6- Logistic regression model with prescribers’ behaviours, attitudes and perceptions as 
outcome 
Outcome (Behaviour/perception) 
Adjusted OR* for effect of 
1 unit increase in 
knowledge score 
95% CI p-value 
Antibiotics are overused in South Africa 
Agree 1.078 0.75, 1.54 0.68 
Antibiotic resistance is a significant problem in South Africa 
Agree 1.63 0.95, 2.78 0.073 
Lack of hand disinfection by healthcare workers causes the spread of antibiotic resistance 
Agree 1.064 0.84, 1.36 0.609 
I would like more education on the appropriate use of antibiotics  
Agree 1.36 0.97, 1.87 0.067 
I feel pressure from patients to prescribe antibiotics  
Agree 0.97 0.75, 1.25 0.82 
The patient expects an antibiotic, so I prescribe even when unnecessary  
Agree 0.88 0.69, 1.1  0.27 
I think other doctors often prescribe antibiotics when they are not necessary  
Agree 0.89 0.707, 1.13 0.33 
Better use of antibiotics will reduce levels of antibiotic resistance 
Agree 1.21 0.57, 2.56 0.608 
To decrease AMR, narrow spectrum antibiotics should be used instead of broad spectrum antibiotics where possible 
Agree 1.409 1.033, 1.92 0.03 
I feel confident to prescribe antibiotics appropriately 
Agree 0.94 0.72, 1.24 0.67 
Antibiotics don’t need to be absolutely necessary,  I just need to think they may help the patient so I prescribe when not necessary 
Agree 0.78 0.57, 1.073 0.12 
Antibiotics can’t harm the patient if they aren’t needed so I prescribe when not necessary 
Agree 0.55 0.33, 0.908 0.02 
I’m concerned about malpractice claims so I prescribe when not necessary 
Agree 0.95 0.73, 1.23 0.71 
I only prescribe antibiotics when  absolutely necessary 
Agree 1.069 0.84, 1.35 0.57 
More resources to educate patients  I would value more resources to educate patients to improve my antibiotic prescribing  
Agree 1.28 0.86, 1.93 0.21 
More data on local antimicrobial resistance  I would value the following resources to improve my antibiotic prescribing  
Agree 1.26 0.73, 2.2 0.408 
When antibiotics are not necessary, I explain features which, if they develop, should prompt  them to seek further medical 
assistance 
Often 1.76 1.01, 3.074 0.046 
When antibiotics are not necessary, I prescribe symptomatic relief 
Often 1.34 0.96, 1.88 0.081 
*Adjusted for age and  type of practitioner       
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Discussion 
We found that mean knowledge scores among patients and providers were 
suboptimal (patients 9/14; prescribers 5/7) and that poor knowledge was associated with 
perceptions and behaviours that could lead to ABR. We identified a large proportion of 
patients who were interested in alternatives to antibiotics. A large proportion of prescribers 
wanting educational material on ABR and for interactions with patients, findings suggest that 
there is substantial opportunity for intervention to reduce harmful practices. 
Comparison with Other Studies 
This project has yielded similar results to existing literature, in that prescribers feel 
that ABR is a big issue, but not in their specific practices (8,16). Prescribers feel a large 
amount of pressure from patients, and self-reported as giving in to this pressure which is 
similar to a study where 40% of respondents stated they would prescribe antibiotics to meet 
a patient’s expectations (10). Many patients do not show a full understanding of ABR, which 
was also shown in the Jin et al study which showed that the majority of respondents believed 
that ABR occurs when the human body becomes resistant to the antibiotic (17). A novel 
finding of the study is that there are statistically significant associations between knowledge 
scores and certain destructive and protective use and prescribing behaviours. If knowledge 
levels are changed, it could be possible to influence these behaviours. 
Strengths and Limitations 
This study is important in that it offers insight in to South African private practice 
patients’ and prescriber’s knowledge, attitudes and perceptions and offers potential 
intervention points.  However, the methods of this project place limitations on the 
generalisability of results; convenience sampling was used, and the project was conducted 
solely in the private health care sector. Selection bias could have occurred as only literate 
and/or computer literate participants would have opted in to complete the survey, and people 
with certain traits may have been more prone to accepting, such as those who felt confident 
about their knowledge of ABR or prescribers who were interested in continuing their 
professional development. A further selection bias factor is that only patients who were 
already at GP practices were requested to complete the survey and these participants could 
have more knowledge of available treatments such as antibiotics than those who are not 
integrated into this sector of the health care system. The sample size of nurse prescribers 
was very small and so results will only reflect doctor prescribers’ knowledge, attitudes and 
perceptions. There was no mechanism in place to ensure that people did not complete the 
survey more than once, but given that the study took some time to complete and there was 
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no specific incentive to participate, double completions were unlikely. Social desirability bias 
could be introduced as the accuracy of answers could not be assessed as they are self-
reported and anonymous, but this was minimised as the surveys were anonymous. Further 
research using alternate sampling methods is needed to remove the effects of these biases 
and confounders.  
Potential Interventions 
This study has yielded information which may assist in planning interventions to slow 
down ABR. Responses from patients included 59% (n= 238) stating that if antibiotics were 
not needed, they would be happy if the doctor explained to them the best over the counter 
treatment options, 36% (n= 144) stated they would be satisfied with a vitamin injection, and 
44% (n= 177) stated they would want reassurances and information about the illness. This is 
useful information which could be passed on to prescribers so that they learn alternate 
strategies which have been shown to be successful by others in the field.  
Many prescribers (n=156, 86%) stated they wished to have more education on the 
appropriate use of antibiotics. Prescribers stated that they would value clearer guidelines to 
improve their antibiotic prescribing in hard copy (78%), on smart phone apps (77%) or on 
interactive internet platforms (76%). These could be useful mediums to use when conducting 
intervention programs.   
Interventions can include developing communication aids for prescriber/ patient 
interactions as 91% of prescribers requested education resource aids for discussions on 
ABR with patients. The majority (96%) of prescribers requested data on local ABR, which 
shows the need for further research into this crisis, and the importance of the dissemination 
of all research findings. 
Educational programs for both patients and prescribers which have been shown to 
be successful in a range of settings (18), could be an effective intervention in South Africa. 
Education programs could utilise all forms of media, social, television and radio to run the 
education campaigns, further research on the most effective tools should be conducted, and 
proven methods should then be continued. 
These suggestions show useful pathways that could be used to educate both 
patients and prescribers on the damage of over prescription, and about the ABR crisis. 
Interventions should focus on increasing knowledge about ABR, which could then have an 





Our study demonstrates gaps in patient and prescriber knowledge that are associated with 
potentially harmful perceptions and behaviours regarding antibiotic use. These associations 
together with our finding that patients and prescribers would like more education on ABR, 
suggest that educational tools and patient-provider communication tools could promote 
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Knowledge Questions (Correct answers in bold)
1.       Which of the following is true? (True/False/Unsure) n True False Unsure
a)       K01a Antibiotics are good for treating germs called viruses 393 52.93% 39.19% 7.89%
b)      K01b Antibiotics are good for treating germs called bacteria 392 76.53% 15.05% 8.42%
c)       K01c Colds, ‘flu and runny nose are usually caused by germs 
called bacteria 389 61.70% 28.02% 10.28%
d)      K01d Our body has ‘good’ bacteria which keeps us healthy 395 81.52% 9.37% 9.11%
e)      K01e Antibiotics can be harmful by killing the ‘good’ bacteria 391 62.15% 20.97% 16.88%
f)        K01f Antibiotics only kill the ‘bad’ bacteria that make you sick 391 34.94% 53.92% 11.14%
g)       K01g People can be allergic to antibiotics 395 86.33% 6.08% 7.59%
h)      K01h Antibiotics can cause diarrhoea 391 73.66% 10.74% 15.60%
i)        K01i All people with a sore throat need antibiotics 388 14.69% 74.74% 10.57%




k)       K01k People with pneumonia need antibiotics 390 68.46% 11.28% 20.26%
l)        K01 l Antibiotics are needed for most urine infections 393 58.02% 24.68% 17.30%
2.    Which of the following are true? (True/False/Unsure) n True False Unsure
a)       K02a Antibiotics do not have side-effects 396 11.87% 79.04% 9.09%
b)      K02b Antibiotics can upset your body’s natural balance 393 77.61% 10.18% 12.21%
Beliefs n Agree Disagree Unsure
c)       B02c It’s important for me to finish the course of antibiotics  I’ve 
been prescribed 394 89.85% 7.36% 2.79%
d)      B02d If people demand an antibiotic, the doctor / nurse should 
give it to them 393 11.96% 81.17% 6.87%
e)      B02e Antibiotics should be available without a prescription 392 11.99% 82.65% 5.36%
f)        B02f Antibiotics are strong and you should only take themwhen 
you really need them 392 81.63% 13.52% 4.85%
Demographics
Gender n Female Male
365 72.05% 27.95%
Your age n <25 25-34 35-44 45-54 55-64 >65
379 8.44% 26.65% 24.27% 19.00% 14.51% 7.12%






366 1.37% 6.83% 54.10% 25.41% 12.30%
56 
3. With regard to antibiotic resistance, which of the following are
true n True False Unsure
a) B03a When people take too many antibiotics their body becomes
resistant to them 390 75.64% 13.59% 10.77%
b) B03b When people take too many antibiotics the germs becomes
resistant to them 389 68.89% 13.62% 17.48%
c) B03c Antibiotics will work less well in future if we over-use them
now 387 64.34% 20.93% 14.73%
d) B03d Antibiotic resistance is likely to be very costly to the world
379 58.84% 15.57% 25.59%
e) B03e Scientists will discover new antibiotics if the current ones
stop working 384 42.71% 18.23% 39.06%
4. When is it most important to have antibiotics?
(True/False/Unsure) n True False Unsure
a) B04a When the doctor or nurse thinks I have a bacterial infection
383 72.85% 16.45% 10.70%
b) B04b When I have been sick for a long time 382 54.97% 31.15% 13.87%
c) B04c When I am very sick 381 58.01% 27.82% 14.17%
d) B 04d When I tried simple remedies but they didn’t work 380 50.79% 36.58% 12.63%
e) B04e It’s not about how sick I am, it depends what kind of illness I
have 382 83.51% 8.90% 7.59%
5. B05  Have you ever been to the clinic specifically because you wanted an antibiotic for you or your child?
n %
Yes (Continue to question 6) 31.68%
No (Go to question 7) 68.32%
6. B06 If yes, what were your beliefs about antibiotics? (Tick all
that apply)
n
% of those 
who said yes 
to 5
a) I thought antibiotics would make me / my child better 95 24.87%




c) Antibiotics are harmless so it’s better to be safe 31 8.12%
d) I believed they would help me get back to work sooner 64 16.75%

















If yes, what did the doctor / nurse do? (tick all that apply)
n
% of those 
who said yes 
to 7








c)       Explained what to expect in terms of symptom resolution 68 18.33%
d)      I was given written information about why antibiotics would not 
help and may cause harm
31
8.36%








g)       I was prescribed symptomatic relief 103 27.76%
h)      I was given a delayed prescription for antibiotics (a prescription I 





8.       A08 If you or your child had a cough or cold and the doctor or 
nurse said you didn’t need antibiotics, which of the following is likely 
to leave you satisfied with the consultation? (tick all that apply)
n
% of total 
respondents
a)       Advice on what to buy over the counter 238 59.06%
b)      A different medicine that is only available on prescription 134 33.25%
c)       A homeopathic remedy 23 5.71%
d)      An injection of vitamins 144 35.73%
e)      Referral to a traditional healer 23 5.71%
f)        Information and reassurance about the illness 177 43.92%
g)       I would only be satisfied if I was given an antibiotic 52 12.90%
9.       A09Which of the following apply to you? (True/False/Unsure) n True  False Unsure
a)       I have taken antibiotics that were prescribed for a friend or 
family member 355 10.42% 87.32% 2.25%
b)      I have saved unused antibiotics to use at a later time 362 17.68% 80.11% 2.21%
c)       I have given my antibiotics to a friend or family member 358 12.85% 84.92% 2.23%
d)      I’ve exaggerated my symptoms to get antibiotics 360 8.33% 87.22% 4.44%
10.       A10 How do you feel when the doctor or nurse prescribes 
antibiotics (Yes/Unsure/No) n True  False Unsure
a)       Relieved that the doctor/nurse realises I am sick 347 43.23% 47.55% 9.22%
b)      Happy because my visit was justified 335 34.03% 59.70% 6.27%
c)       Annoyed because too many antibiotics are being prescribed 328 25.91% 61.89% 12.20%
d)      Worried because I prefer not to take antibiotics unless absolutely 
necessary 340 57.65% 35.00% 7.35%
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Appendix 4- Prescriber Questionnaire (with percentile answers) 
 












Where do you practice? 165 92,12% 4,24% 3,64%  
      
 n Doctor  Nurse    
Nurse or doctor 167 98,20% 1,80%   
      
 n 25-34 35-44 45-54 >55  
Your age 163 7,98% 31,29% 17,79% 42,94% 
      
Approximately how many patient 
consultations do you perform a day? 
n <5 6-23 15-24 >24 
44 6,82% 0,00% 40,91% 52,27% 
 
 
Beliefs and attitudes 
 










a.      B01a Antibiotics are overused in South Africa 157 98,09% 0,00% 1,91% 
b.      B01b Antibiotic resistance is a significant problem in South 
Africa 
157 96,82% 1,27% 1,91% 
c.       B01c New antibiotics are available to deal with the problem of 
resistance 
156 19,87% 69,23% 10,90% 
d.      B01d Inappropriate use of antibiotics drives antibiotic 
resistance 
156 99,36% 0,64% 0,00% 
e.      B01e Better use of antibiotics will reduce levels of antibiotic 
resistance 
156 98,08% 1,28% 0,64% 
f.        B01f Use of broad spectrum antibiotics when equally effective 
narrower spectrum antibiotics are available can increase antibiotic 
resistance 
156 84,62% 5,13% 10,26% 
g.      B01g Patients not finishing their course of antibiotics drives 
resistance 
157 85,99% 8,28% 5,73% 
h.      B01h Lack of hand disinfection by healthcare workers causes 
the spread of antibiotic resistance 
156 58,33% 31,41% 10,26% 
I.        B01j A good knowledge of antibiotics is important to my work 
as a doctor 
156 100,00% 0,00% 0,00% 
j.        B01j I would like more education on the appropriate use of 
antibiotics 
156 85,90% 12,18% 1,92% 
k.       B01k I feel confident to prescribe antibiotics appropriately 154 73,38% 11,69% 14,94% 
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l.        B01l I feel pressure from patients to prescribe antibiotics 154 70,13% 25,97% 3,90% 
 
2.      B02 How often do you use the following resources to guide 









a.      B02a. Textbooks 157 27,39% 19,75% 52,87% 
b.      B02b. Medical journals 156 14,10% 27,56% 58,33% 
c.       B02c. International/national/provincial/institutional guidelines 156 16,67% 38,46% 44,87% 
d.      B02d. Tablet or smartphone apps 153 47,06% 27,45% 25,49% 
e.      B02e. Consultation with colleagues 154 12,99% 21,43% 65,58% 
f.        B02f. Consultation with specialists in microbiology/infectious 
diseases 
156 25,00% 27,56% 47,44% 
g.      B02g. Pharmaceutical representative 156 28,21% 21,79% 50,00% 
 
 
3.      B03 How much do you agree with the following statements? I 










a.      B03a.Interactive internet based courses  151 76,82% 9,93% 13,25% 
b.      B03b. Clearer guidelines for tablet or smartphone apps 149 77,18% 12,08% 10,74% 
c.       B03c.Clearer guidelines in written form 152 77,63% 13,16% 9,21% 
d.      B03d.Weekend courses by specialists 151 68,21% 20,53% 11,26% 
e.      B03e.Weekend courses by General Practitioners 48 29,17% 41,67% 29,17% 
f.        B03f.Better access to diagnostic tests such as point-of-care 
CRP 
148 71,62% 11,49% 16,89% 
g.      B03g.More resources to educate patients 150 91,33% 5,33% 3,33% 
h.      B03h.More data on local antimicrobial resistance 153 96,08% 2,61% 1,31% 
 
4.      B04. If a patient expects an antibiotic but you don’t think it’s absolutely necessary, how often do 
you prescribe them? 
n % 




b.      Often >70% 5,88% 
c.       About half the time  50% 31,76% 
d.      Rarely <30% 38,24% 
e.      Almost never <10% 22,35% 
5.      B05. If you prescribe antibiotics that are not absolutely necessary, what are 




% of all respondents 
a.      B05a. The patient expects an antibiotic 73 41,71% 
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b.      B05b. Antibiotics don’t need to be absolutely necessary,  I just need to think 
they may help the patient 
21 12,00% 
c.       B05c.Antibiotics can’t harm the patient if they aren’t needed 6 3,43% 
d.      B05d.Patients can’t afford laboratory tests 66 37,71% 
e.      B05e.I’m concerned about malpractice claims 38 21,71% 
f.        B05f.Not applicable – I only prescribe antibiotics when  absolutely necessary 62 35,43% 
   
6.      B06.How often do you think other doctors prescribe antibiotics when they 








b.      Often >70% 53,61% 
c.       About half the time  50% 25,90% 
d.      Rarely <30% 5,42% 
e.      Almost never <10% 1,20% 
 
7.      B07. When the patient has an infection but antibiotics are 










a.      B07a.Explain that the patient has a virus and antibiotics will 
not help 
148 0,68% 86,49% 12,84% 
b.      B07b.Explain that antibiotics have side-effects  which could 
make them feel worse 
145 17,24% 45,52% 37,24% 
c.       B07c.Explain what to expect in terms of duration of 
symptoms 
141 4,96% 75,18% 19,86% 
d.      B07d.Explain features which, if they develop, should prompt  
them to seek further medical assistance 
51 3,92% 84,31% 11,76% 
e.      B07e.Given written information about why antibiotics would 
not  help and may cause harm 
142 77,46% 4,23% 18,31% 
f.      B07f.Given written information about what to expect in terms 
of symptom resolution 
141 75,18% 5,67% 19,15% 
g.      B07g.Explain the need for follow-up if symptoms don’t 
improve 
144 0,00% 89,58% 10,42% 
h.       B07h.Prescribed symptomatic relief 144 4,86% 86,11% 9,03% 
I.      B07i.Give a delayed prescription for antibiotics (a 
prescription that can only be collected after a few days if the 
patient isn’t better) 
145 30,34% 28,97% 40,69% 
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j.      B07j.Prescribe antibiotics anyway 140 54,29% 5,00% 40,71% 
 
Knowledge Questions (Correct answers in bold) 
  
8.      K08. A 30-year-old female patient with no significant past medical history asks you to prescribe an antibiotic. She has had a 
cough productive of green sputum for 1 week following an upper respiratory tract infection. The vital signs and examination of the 
chest are normal. What is the correct course of action? 
 
n = 48 
 a.      Prescribe an antibiotic for community acquired pneumonia 4,17% 
 
b.      Give symptomatic treatment, advice, and information about the condition 
77,08% 
 c.       Prescribe an antibiotic for bronchitis 16,67% 
 d.      Refer the patient to hospital 2,08% 
 e.      Investigate for tuberculosis 0,00% 
  
9.      K09. A 35-year-old man who has well controlled HIV (CD4 360 and viral load <50) has been coughing for 2 weeks. He was given 5 
days of co-amoxiclav which have not helped. He has been feeling a little feverish and sweaty but examination is unremarkable. What is 
your preferred strategy? 
 
n = 164 
  a.      Reassure him that he has a viral infection that will resolve spontaneously 17,68% 
  b.      Prescribe a second course of co-amoxiclav 0,61% 
  c.       Prescribe moxifloxacin to cover atypical / resistant respiratory pathogens 8,54% 
  d.      Prescribe azithromycin to cover atypical / resistant respiratory pathogens 10,98% 
  e.      Test sputum for TB 62,20% 
        
10.      K10. A 66-year-old man who is hypertension with mild chronic renal impairment has been feeling ‘under the weather’ for 2 weeks. 
He is coughing and producing green sputum. His respiratory rate is 32 and blood pressure 100/55. There is bronchial breathing with 
crepitations in the left lower zone. What is your preferred course of action? 
 
n = 108 
  a.      Refer immediately to hospital with likely diagnosis of pneumonia 65,74% 
  b.      Test with sputum for TB  1,85% 
  c.       Prescribe co-amoxiclav orally and plan to review in a few days 22,22% 
  d.      Prescribe moxifloxacin orally and plan to review in a few days 7,41% 
  e.      Give bronchodilators in your clinic and see how he responds 2,78% 
  
    
11.      K11. A 20-year-old woman is complaining of mild suprapubic pain for 2 days. She is not pregnant. Urine dipstick shows protein 
1+, Blood neg, leukocyte esterase neg, nitrites neg. What is your preferred course of action? 
 




a.      Send a urine sample for MC+S and prescribe an antibiotic for uncomplicated cystitis 16,98% 
  b.      Prescribe an antibiotic for uncomplicated cystitis   10,69% 
  
c.       Consider UTI unlikely and look for alternative causes of proteinuria and suprapubic pain 
66,67% 
  d.      Prescribe an antibiotic for uncomplicated cystitis and investigate reasons for protein and blood in the urine 5,66% 




  12.      K12. A 30-year-old man has had a sore throat and runny nose for 5 days but is otherwise well. His oropharynx is inflamed; there 
is no exudate on the tonsils and no tender cervical adenopathy. He asks for and antibiotic for ‘Strep throat’. What is your preferred 




a.      Give advice about symptomatic treatments and information about expected duration of illness 
81,65% 
  b.      Investigate for diphtheria 1,27% 
  c.       Prescribe penicillin VK 1,27% 
  d.      Investigate for acute EBV infection (glandular fever) 3,80% 





13.      K13. A 25-year-old woman presented with a UTI last week, your colleague prescribed ciprofloxacin as a single dose and sent a 
urine sample which shows E.Coli resistant to ciprofloxacin and sensitive to co-amoxiclav, gentamicin & ertapenem. She has returned as 
she still has dysuria but she is no worse. What would be your preferred course of action?  
 
n = 162 
  a.      Refer to hospital for treatment of this resistant organism 4,32% 
  b.      Prescribe ciprofloxacin for 3 days 0,62% 
  c.       Prescribe co-amoxiclav for 3-5 days 84,57% 
  d.      Prescribe oral gentamycin for 3 days 1,85% 





14.      K14. A 40-year-old woman has had 3 days of profuse watery diarrhoea up to 8 times per day. There is no blood or mucus and 
no-one else in the family is unwell. She is not clinically dehydrated. What would be your preferred course of action? 
 
n =163 
  a.      Prescribe oral rehydration solution and anti-diarrheal medication 70,55% 
  b.      Send stool for MC&S and await results 20,25% 
  c.       Prescribe metronidazole orally 1,23% 
  d.      Prescribe ciprofloxacin orally 4,29% 
  e.      Prescribe ciprofloxacin and metronidazole orally 3,68% 
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